What VLAW Can Do For You VanDerGinst Law Commitment Meet The VanDerGinst Law Team VanDerGinst Law Testimonials VanDerGinst Law News Espanol VanDerGinst Law Home Contact VanDerGinst Law
Accident Cases Dangerous Drugs Medical Devices Defective Products
Pollutants Medical Malpractice Consumer Fraud Other Resources
Our Scrapbook Legal Dictionary For Injury Clients Home Safety Tips
Lawyer Values Message to Attorneys Chicago Injury Lawyer Articles

Dangerous Drugs

A personal injury lawyer from VanDerGinst Law, P.C. knows what encompasses drug litigation, drug lawsuits, drug side effects or any and all things pertaining to drugs injuring those who use them for medical treatment. While drugs are often tested ad nauseum to ensure they are safe for consumption by the public, dangerous drugs sometimes make their way to the public market. When a drug you use or haved used in the past is placed under a drug recall or a is suspended from sale pending further investigation, your first call should be to an educated and experienced drug lawyer.

Side effects are common knowledge in regards to modern drugs. So long as the health of the patient is advanced further by the use of the drug than it is adversely affected by its side effects, a drug will remain in use and on the free market. However, despite rigorous testing and regulation, drugs sometimes cause dangerous side effects after their introduction to market and patients can be left unaware of potential dangers.

When a drug causes dangerous side effects, including illness and death, the drug company responsible for the drug's manufacture is liable for any damages caused to patients who suffered from any undocumented risk of harm stemming from the drug treatment. In addition, medical professionals who prescribed the drug may also share liability under certain circumstances.

Mass torts is the term used to refer to pending litigation against the manufacturer of a dangerous drug. The Food and Drug Administration (FDA) regulates the pharmaceutical industry and issues numerous warnings and recalls regarding the safety of drugs every year. Despite the FDA's efforts to protect the consumer, dangerous drugs are still on the market and can result in serious injury or death of the patient. Mass torts are meant to provide people injured by dangerous drugs the ability to seek compensation through the legal system.

By law, drug manufacturers are responsible for injuries incurred by the patient if the product they sell is defective or unreasonably dangerous. A mass tort law firm is dedicated to serving the people who have been injured by dangerous drugs by holding drug manufacturers accountable for their products. Unfortunately, some drugs are still marketed by drug companies even after evidence of serious side effects or death had been noted.

The sale and marketing of dangerous drugs can happen in several ways. For example, the consumer may not be warned of potential serious side effects, the manufacturing process may be flawed, or the product itself may be defective. In all these cases, the manufacturer is liable and can be sued for damages even if they were unaware of the danger. It does not matter how carefully the product was produced or labeled.

Our comprehensive library of drug information serves as a resource to patients across the country who may have suffered as the result of dangerous drug side effects.

If you or a loved one has suffered an injury, illness or death after exposure to a dangerous pharmaceutical, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.


Dangerous Drugs

Abilify Accutane Ace Inhibitors Actonel
Actos Adderall Advair Advil
Aldara Ambien Amiodarone Aptvirus
Aranesp Arava Aredia Aricept
Avandia Avonex Baycol Betaseron
Bextra Bismacine Bitter Orange Campath
Cardizem Celebrex Celexa Chantix
Cipro Cleocin Clozaril Concerta
Cordarone Coreg Crestor Cylert
Cymbalta Cytotec Darvocet Darvon
Daypro DES Dexedrine Dilantin
Diltiazem Duragesic Effexor Elidel
Enbrel Ephedra Estratest Evista
Fen Phen Fleet Enema Foradil Fosamax
Geodon Gleevec Herceptin Humira
Interceed Intergel Ketek Lamictal
Lariam Levaquin Levitra Levodopa
Lexapro Luvox Lymerix Lyrica
Macugen Mellaril Menactra Meningitis
Meridia Metabolife Metadate Methazolamide
Methylin Mirapex Mobic Motrin
Natrecor Neurontin Neutrospec Novantrone
Novoseven Orthoevra Oxycontin Pacerone
Palladone Paxil Permax Plavix
Ppa Premarin Premphase Prempro
Protopic Prozac Raptiva Reglan
Relafen Remeron Remicade Reminyl
Renu RenuMulti Requip Rezulin
Risperdal Ritalin Serevent Seroquel
Sinemet Soriatane Strattera Symbyax
Tamoxifen Tequin Terbutaline Thimerosal
Tiazac Trasylol Trileptal Tysabri
Viagra Vincristine Vioxx Wellbutrin
Xenadrine Xigris Zelnorm Zevalin
Zicam Zoloft Zometa Zyprexa

More Information
  • Stevens Johnson Syndrome - A rare, potentially fatal skin disorder associated with a large number of prescription drugs as a potential side effect.
 

Links on the Web

Food and Drug Administration--Recalls

Recall information from FDA
Wed, 02 Jul 2008 18:11:00 GMT

Jack Distribution, LLC. Issues a Voluntary Nationwide Recall of Select Lots of Rize 2 The Occasion Capsules and Rose 4 Her Capsules (July 1)

Jack Distribution, LLC, and its wholesale distributors G and N Works, Inc., and Devine Distribution, Inc., announced today that they are conducting a voluntary nationwide recall of the following lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. (Rize 2 lot numbers CG-84 expires 11/10, GD-98 expires 08/10, CC-06 expires 06/10, 709 expires 09/10, CG-79 expires 11/10) (Rose 4 Her lot number CG-78 expires 11/10).

Click here to read this Dangerous Drugs news article.

Mon, 30 Jun 2008 20:32:00 GMT

Sage Products Inc. Issues Voluntary Recall of 2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation (June 27)

As a precautionary measure, Sage Products announced a voluntary recall of limited lots of 2 Percent Chlorhexidine Gluconate (CHG) Cloth Patient Preoperative Skin Preparation product. Testing of bulk 2 Percent CHG solution from an outside supplier was found positive for Burkholderia cepacia (B. cepacia).

Click here to read this Dangerous Drugs news article.

Mon, 30 Jun 2008 12:35:00 GMT

Giant Food Alerts Customers to Voluntary Recall of Giant Brand Garlic Bread and Garlic Spread (June 27)

Giant Food has announced a voluntary recall of Giant brand garlic bread and garlic spread products sold in its Bakeshop as the items contain milk products which are not declared on the labels. Giant removed from its shelves all 16 ounce packages of Giant brand garlic bread and all 16 ounce packages of Giant brand garlic spread products.

Click here to read this Dangerous Drugs news article.

Mon, 30 Jun 2008 12:35:00 GMT

Stop and Shop Alerts Customers to Voluntary Recall of Stop and Shop Brand Garlic Bread and Garlic Spread (June 27)

The Stop and Shop Supermarket Company has announced a voluntary recall of Stop and Shop brand garlic bread and garlic spread products sold in its Bakeshop as the items contain milk products which are not declared on the labels. Stop and Shop removed from its shelves all 16 ounce and 9 ounce packages of Stop and Shop brand garlic bread and all 16 ounce packages of Stop and Shop brand garlic spread products.

Click here to read this Dangerous Drugs news article.

Thu, 26 Jun 2008 12:05:00 GMT

Bay Valley Foods Issues Allergy Alert on Undeclared Milk in Mislabeled Kroger Chicken Noodle Soup (June 24)

The recalled product, Kroger Chicken Noodle Soup, comes in 10.5 ounce cans and is marked with lot code 52104098, and a "best before" date code of 40910 (April 9, 2010) that can be found on the bottom of the can. Consumers are urged to return the product to the store where it was purchased for a full refund.

Click here to read this Dangerous Drugs news article.

Thu, 26 Jun 2008 11:08:00 GMT

Matterhorn Group Inc. Announces Voluntary Recall of Astro Pops and Missile Pops 3.5 oz Cherry Pineapple Frozen Novelty Pops in Arizona, Nevada and California due to Safety Hazard (June 18)

Matterhorn Group Inc is recalling certain date coded product of their Rainbow Glacier "Astro Pops" water ice frozen novelty pops, Cherry Pineapple Swirl 3.5 oz size 12 count bag pack, with tag closure "Best by JUN 03-09", "Best by JUN 04-09" and "Best by JUN 05-09" sold through the Wal-Mart stores located in California and Arizona, Sunnyside Farms "Missile Pops" Cherry Pineapple in 3.5 oz. size 12 count bag packages, with tag closure of "Best By JUN 02-09", "Best by JUN 03-09", and "Best by JUN 04-09" sold through the California stores of grocery retailers Save Mart and Raley?s, and Vitafreze Frozen Astronot Pops 3.5 oz size 12 count bag packages, with tag closure of "Best By JUN 02-09" sold in California. The products are being recalled because they may contain pieces of hard plastic. Only the noted product date codes listed are affected.

Click here to read this Dangerous Drugs news article.

Click here for archived Dangerous Drugs news.


Medical Devices News From Medical News Today

Latest Medical Devices News From Medical News Today.
Tue, 08 Jul 2008 02:00:00 PDT

Medtronic Starts International Market Launch And U.S. Clinical Trial Of Endurant Stent Graft

Expanding the application of endovascular aortic repair around the world, Medtronic, Inc. (NYSE: MDT), announced two major milestones: the international market launch of the Endurant Abdominal Stent Graft System and the first implants of this next-generation medical device in the U.S. clinical trial. International Market Launch The Endurant Stent Graft was CE (Conformité Européene) marked last week, and Medtronic will begin commercialization in mid-July.

Click here to read this Dangerous Drugs news article.

Tue, 08 Jul 2008 02:00:00 PDT

New Insight To Demineralization

From toothpaste to technology, noncrystalline or amorphous silica is an active ingredient in a myriad of products that we use in our daily lives. As a minor, but essential component of vertebrate bone, an understanding of silica reactivity in physiological environments is crucial to the development of successful biomedical implants and synthetic materials with bone-like properties.

Click here to read this Dangerous Drugs news article.

Tue, 08 Jul 2008 01:00:00 PDT

NYC First: Complex Aneurysm Treated Using New Fenestrated Endograft Stent

In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol. The stent graft is designed to treat a complex form of abdominal aortic aneurysms in which the weakened, enlarged vessel wall is too close to the arteries leading to the kidneys.

Click here to read this Dangerous Drugs news article.

Tue, 08 Jul 2008 00:00:00 PDT

Microbial Solutions Scoops Ford Engineering Excellence Award For Bacterial Technology

Microbial Solutions Ltd, an Oxfordshire company developing innovative technologies to assess and cleanse toxic metal working fluids used in the engineering industry, has won a Ford Motor Company TMM Engineering Excellence Award. The Ford TMM Engineering Excellence Award is given to individuals or teams who have made a significant contribution to engineering or organizational excellence within engine and transmission manufacturing.

Click here to read this Dangerous Drugs news article.

Sun, 06 Jul 2008 02:00:00 PDT

Visualizing Atomic-Scale Acoustic Waves In Nanostructures

Acoustic waves play many everyday roles - from communication between people to ultrasound imaging. Now the highest frequency acoustic waves in materials, with nearly atomic-scale wavelengths, promise to be useful probes of nanostructures such as LED lights. However, detecting them isn't so easy.

Click here to read this Dangerous Drugs news article.

Sun, 06 Jul 2008 00:00:00 PDT

New IVF Lab In A Box Increases Clinical Pregnancy Rates By 50% - European Launch Of Ac-tive(R) IVF System At ESHRE 2008, Barcelona

Ruskinn Life Sciences is heralding a breakthrough in IVF treatment at the European Society of Human Reproduction and Embryology (ESHRE) annual conference with the unveiling of Ac-tive®, an innovative new technology capable of significantly boosting in-vitro fertilisation (IVF) conception rates. The state-of-the-art gas controlled device mimics 'in-utero' conditions for all IVF manipulations in a single workstation.

Click here to read this Dangerous Drugs news article.

Click here for archived Dangerous Drugs news.


Dangerous Drugs, Injury, JulyDangerous Drugs, Injury, July
No fee unless we win your accident or injury case. Fields with * must be filled in.

* Full Name
* Email Address
* Phone Number
Cell Number
Address including City, State, & Zip Code
Date of Birth of Injured Person
State Where Accident/Incident Occurred
Describe Accident/Incident and Injuries
Yes, I agree to the VanDerGinst Law disclaimers. Review the disclaimers.
Yes, I would like to receive the VanDerGinst Law Monthly E-Newsletter.
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
Dangerous Drugs, Injury, July
The Civil Justice System Know Your Rights Dangerous Drugs, Injury, July
Attorneys Help UnSung Heroes Consumer Attorneys Care Dangerous Drugs, Injury, July